Status:
COMPLETED
Fasted Exercise and LDL-C
Lead Sponsor:
University of Bath
Collaborating Sponsors:
King's College London
Zoe Global Limited
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
25-60 years
Phase:
NA
Brief Summary
Cardiovascular disease (CVD) is the leading cause of death in the UK and worldwide with low density lipoprotein cholesterol (LDL-C) being one of the most important modifiable risk factors. Physical ac...
Eligibility Criteria
Inclusion
- Age 18-65 years
- Body mass index 20-40kg/m2
- Physically inactive (exercise for less than 150 minutes per week)
Exclusion
- Weight instability (\>5kg change in body mass over last 6 months)
- Diagnosis of diabetes or CVD
- Pregnant or lactating
- Any medical condition or medication that could introduce bias into the study (eg. lipid disorders, lipid or glucose metabolism altering medications eg statins)
Key Trial Info
Start Date :
March 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2024
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT05279014
Start Date
March 30 2022
End Date
August 30 2024
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department for Health, University of Bath
Bath, Bath, United Kingdom, BA2 7AY